Non-Invasive Glucose Monitoring Technologies

Non-Invasive [Glucose Monitoring](/) Technologies

As of October 2026, no non-invasive glucose monitor has replaced the fingerstick. The FDA says it has not authorized, cleared or approved any smartwatch or smart ring that measures or estimates blood glucose on its own, and in February 2024 it told people not to buy or use them [1]. For anyone who tests with a meter and strips, the lancet stays in the kit.

What non-invasive monitoring would change for strip users

A standard home glucose test needs a drop of blood from a puncture at the fingertip. A 2022 review of bloodless monitoring products opens with exactly that point, and with the strong demand for devices that skip the pain [2]. A non-invasive monitor would read glucose through intact skin, usually with light or radio waves. No lancet, no strip, no vial to keep track of.

The catch is in how the number is produced. A meter measures glucose in the blood itself: the lancet reaches the small capillaries in the skin, and an enzyme-based sensor on the strip turns the glucose in that drop into an electrical current [3]. A non-invasive device has to infer glucose from a physical signal passing through tissue. That signal is faint. Glucose makes up only about 0.07 to 0.1% of plasma, and water, pigments and proteins in tissue also change how much light is absorbed [4].

What the FDA warned about in 2024

The FDA's safety communication, dated February 21, 2024, targets the promise strip users would most like to hear. Sellers claim their watches and rings measure blood glucose "without requiring people to prick their finger or pierce the skin," and the FDA says these devices do not directly test blood glucose [1]. Dozens of companies make them, under many brand names [1].

The agency's worry is what a wrong number leads to. An inaccurate reading can lead to the wrong dose of insulin, a sulfonylurea or another drug that lowers glucose quickly, and too much of these drugs can cause dangerously low glucose within hours [1]. The warning does not cover watch apps that display readings from an FDA-authorized CGM, which pierces the skin [1]. As of October 2026 the page still carries its February 2024 date, and its advice is to talk with a health care provider about an authorized device [1].

What has and hasn't been authorized

Here's what surprised us. The FDA keeps a product code for this exact idea, NCT, "Instrument, Glucose, Noninvasive Technology," and as of October 2026 its classification record links to a single premarket approval, P990026 [5]. That approval belonged to the GlucoWatch Automatic Glucose Biographer, approved on March 22, 2001 [6]. Its label is the part a strip user should notice. The GlucoWatch was an adjunctive device, meant "to supplement, not replace," the information from standard home glucose monitoring devices such as meters [6].

The GlucoWatch drew glucose out through the skin with a small electric current, and it had to be calibrated with a standard glucometer [4]. In a six-month trial in 200 children and teens with type 1 diabetes, adding the newer G2 Biographer to standard monitoring did not improve HbA1c (a lab measure of longer-term average glucose) [7]. Use dropped over the six months, and skin irritation was the most common reason participants gave (76%) [7]. The FDA lists the approval as withdrawn on April 23, 2010 [6].

Optical devices haven't filled the gap. The 2022 review counted 28 non-invasive optical glucose products and noted that none had been approved by the FDA [2]. Our CGM hub's article on non-invasive glucose monitoring technology covers what the FDA has authorized instead, from over-the-counter CGMs to an intradermal microsensor.

Why the fingerstick is still the reference

Meters are held to a written accuracy bar. The FDA's guidance for over-the-counter meters asks manufacturers to show that 95% of results fall within ±15% of a laboratory comparator method across the meter's full measuring range, and 99% within ±20% [8]. The FDA's stated reason is that people with diabetes use these results to make critical treatment decisions [8]. CGMs are judged against a laboratory analyzer too; the FDA's review of the Dexcom G7 compared its readings with a YSI 2300 STAT Plus glucose analyzer [9]. Our article on ISO 15197:2013 accuracy standards covers the international bar meters are measured against.

Timing is the other reason a sensor and a strip can disagree. CGMs read glucose in interstitial fluid, the fluid around the cells just under the skin, and a 2009 review found that sensor readings can trail blood glucose by 5 to 10 minutes when levels change quickly [3]. The same review explained that, at the time, sensor manufacturing had not reached the accuracy and precision of meter strips, so sensors had to be calibrated against meter readings [3].

Many CGMs have since dropped routine calibration, but the meter hasn't left their labeling. The Dexcom G7 is factory-calibrated and authorized to replace fingerstick testing for treatment decisions [9]. Its FDA decision summary still tells users to use a blood glucose meter when sensor readings don't match their symptoms, when the system doesn't show both a number and a trend arrow, and during the 30-minute warm-up [9]. The Eversense 365, a sensor a clinician implants under the skin for up to a year, needs fingerstick calibrations: four in its first phase, one a day through day 13, then one a week [10].

The American Diabetes Association's 2026 Standards of Care say it directly: people using CGM devices must also have access to blood glucose monitoring at all times [11]. How to act on any reading, from a meter or a sensor, is a decision for you and your care team.

What a non-invasive device would have to prove

Meters and CGMs both earn their place by matching a laboratory analyzer [8][9]. A watch or ring that wanted to replace strips would need to do the same while reading a faint signal through tissue [4]. As of October 2026, the only FDA record under the non-invasive glucose product code is an approval that was withdrawn in 2010 [5][6]. Until that changes, a meter and a vial of strips remain the thing people check every other glucose reading against.